Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2023 Filed Mar 7, 2023 21:59 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 1,150 | $190.21 | $218,741.50 |
DisclosureSEC source: 0001209191-23-016816 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,345 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $190.20 to $190.25 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of March 3, 2023, 9,387 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025 and 2,140 on June 2, 2026. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:35 UTC |
Breeden Richard CDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,657 | Not disclosed Strike: $43.92 | Not disclosed |
DisclosureSEC source: 0001209191-23-010662 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option to purchase 4,657 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,657 ordinary shares for $43.92 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 4,657 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,657 ordinary shares for $43.92 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:35 UTC |
Breeden Richard CDirector
|
Exercise / conversionOrdinary Shares | 4,657 | $43.92 | $204,535.44 |
DisclosureSEC source: 0001209191-23-010662 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059708 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938 Underlying: Ordinary Shares · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 98 | $191.91 | $18,807.18 |
DisclosureSEC source: 0001209191-22-059708 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,719 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of December 5, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059708 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of December 5, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:30 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 1,600 | $192.51 | $308,016.00 |
DisclosureSEC source: 0001209191-22-059701 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,495 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $192.48 to $192.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of December 5, 2022, 9,387 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025 and 2,140 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · derivative · entry 9 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271 Underlying: Ordinary Shares · 309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · derivative · entry 8 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,580 Underlying: Ordinary Shares · 138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · derivative · entry 7 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,718 Underlying: Ordinary Shares · 56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 91 | $168.56 | $15,338.96 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 6 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,484 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 5 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 41 | $168.56 | $6,910.96 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 4 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,266 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 17 | $168.56 | $2,865.52 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,169 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053468 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 12, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · derivative · entry 6 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,774 Underlying: Ordinary Shares · 124 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · derivative · entry 5 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,898 Underlying: Ordinary Shares · 482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 37 | $170.19 | $6,297.03 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · nonDerivative · entry 4 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,130 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 11, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · nonDerivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 11, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 142 | $170.19 | $24,166.98 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,043 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 11, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053311 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 11, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 85 | $170.07 | $14,455.95 |
DisclosureSEC source: 0001209191-22-052760 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,703 F1 · shares: 85 shares were withheld from the 289 restricted shares that vested on October 3, 2022. These 85 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Xilas on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 2,275 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 171 | $170.07 | $29,081.97 |
DisclosureSEC source: 0001209191-22-052757 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,310 F1 · shares: 171 shares were withheld from the 493 restricted shares that vested on October 3, 2022. These 171 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 3,956 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 914 | $170.07 | $155,443.98 |
DisclosureSEC source: 0001209191-22-052762 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,601 F1 · shares: 914 shares were withheld from the 2,037 restricted shares that vested on October 3, 2022. These 914 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,037 ordinary shares were awarded to Mr. Carestio on October 1, 2018 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 25,839 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 91 | $170.07 | $15,476.37 |
DisclosureSEC source: 0001209191-22-052761 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,845 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 3, 2022. These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 8,785 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC |
Burton Karen LVP, Controller & CAO
|
Tax withholdingOrdinary Shares | 39 | $170.07 | $6,632.73 |
DisclosureSEC source: 0001209191-22-052758 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,028 F1 · shares: 39 shares were withheld from the 86 restricted shares that vested on October 3, 2022. These 39 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 86 ordinary shares were awarded to Ms. Burton on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 2,397 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 255 on May 31, 2023; 198 on June 1, 2023; 225 on June 2, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025 and 225 on June 2, 2026. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:54 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044586 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,163 Underlying: Ordinary Shares · 842 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:54 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,743 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044586 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 Underlying: Ordinary Shares · 2,743 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,321 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 241 | $62.32 Strike: $203.00 | $15,019.12 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,110 Underlying: Ordinary Shares · 241 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:51 UTC |
Shah Nirav RDirector
|
GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044585 · doc4.xml · derivative · entry 2 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,997 Underlying: Ordinary Shares · 573 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:51 UTC |
Shah Nirav RDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044585 · doc4.xml · derivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:47 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 404 | $203.00 | $82,012.00 |
DisclosureSEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,163 Underlying: Ordinary Shares · 404 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:47 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,759 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:47 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 321 | $62.32 Strike: $203.00 | $20,004.72 |
DisclosureSEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Ordinary Shares · 321 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $20,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:47 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:49 UTC |
Martin Paul EdwardDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044584 · doc4.xml · derivative · entry 1 Martin Paul Edward · CIK 0001700415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,531 Underlying: Ordinary Shares · 1,147 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:43 UTC |
HOLLAND CHRISTOPHER SDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044580 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,464 Underlying: Ordinary Shares · 1,147 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:39 UTC |
FELDMANN CYNTHIA LDirector
|
GrantCareer Restricted Stock Units · Derivative | 74 | $203.00 | $15,022.00 |
DisclosureSEC source: 0001209191-22-044578 · doc4.xml · derivative · entry 3 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,622 Underlying: Ordinary Shares · 74 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $15,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:39 UTC |
FELDMANN CYNTHIA LDirector
|
GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044578 · doc4.xml · derivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,548 Underlying: Ordinary Shares · 573 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:39 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044578 · doc4.xml · derivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:36 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 404 | $203.00 | $82,012.00 |
DisclosureSEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,961 Underlying: Ordinary Shares · 404 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:36 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,557 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:36 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 401 | $62.32 Strike: $203.00 | $24,990.32 |
DisclosureSEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 Underlying: Ordinary Shares · 401 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:36 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044576 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 2,659 | $205.31 | $545,919.29 |
DisclosureSEC source: 0001209191-22-037903 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,936 F1 · shares: This sale of 2,659 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F2 · balance_after: As of June 15, 2022, 8,987 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:00 UTC |
Xilas AndrewSVP and GM, Dental
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,404 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034167 · doc4.xml · derivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Underlying: Ordinary Shares · 6,404 shares Expires 2032-06-02 F2 · derivative.exercise_date: This option becomes exercisable as follows: 1,601 on June 2, 2023, 1,601 on June 3, 2024, 1,601 on June 2, 2025 and 1,601 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:00 UTC |
Xilas AndrewSVP and GM, Dental
|
GrantOrdinary Shares | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034167 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,788 F1 · shares: As of June 2, 2022, 2,564 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 2,564 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 352 on June 2, 2023; 289 on October 2, 2023; 352 on June 3, 2024; 289 on October 1, 2024; 352 on June 2, 2025; 289 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.